Navigation Links
Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
Date:11/7/2012

process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2011 and its most recent quarterly report on Form 10-Q, which are on file with the SEC. Copies of these and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries.

Isis Pharmaceuticals® is a registered trademark of Isis Pharmaceuticals, Inc.  Regulus Therapeutics™ is a trademark of Regulus Therapeutics Inc.  KYNAMRO™ is a trademark of Genzyme Corporation.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vanda Pharmaceuticals Reports Third Quarter 2012 Results
2. Radiopharmaceuticals and Contrast Media: Frost & Sullivan Predicts Market Growth in Europe
3. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Third Quarter 2012 Financial Results
4. Enanta Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
5. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results
6. AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
7. Thom Rowland Joins Arbor Pharmaceuticals as Vice President of Commercial Operations
8. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
9. Jazz Pharmaceuticals Announces Support for National Campaign Designed to Curb Prescription Drug Abuse
10. Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
11. AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... The new report by ... applications, techniques, end users and Geography) Global Size, ... - 2020," indicates that the global DNA diagnostics ... a CAGR of 9.8% from 2014 to 2020. ... effectiveness over alternative diagnostic techniques are factors which ...
(Date:8/28/2014)... Aug. 28, 2014  In recognition of the increased ... from the flu, pneumonia, shingles and other illnesses, ... declared September to be Senior Vaccination Month. Because ... is important that adults ages 65 years and ... CVS pharmacists and MinuteClinic nurse practitioners and physician ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire/ ... market research report is available in ... Therapeutics in Asia-Pacific Markets to 2020 ... Unmet Need in Newly Diagnosed and ... http://www.reportlinker.com/p02343492/Glioblastoma-Multiforme-Therapeutics-in-Asia-Pacific-Markets-to-2020---Novel-Therapeutic-Approaches-Target-High-Unmet-Need-in-Newly-Diagnosed-and-Recurrent-GBM.html Glioblastoma ...
Breaking Medicine Technology:DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9
... N.J., Oct. 17 Ten abstracts providing new,analyses of ... for,MIRCERA(R) will be presented at the upcoming 40th Annual ... Francisco on November 2 - 5,2007. Among the ... PROTOS, STRIATA and RUBRA, and correction studies,including ARCTOS and ...
... MOINES, Iowa, Oct. 16 Protocol Driven ... announced a partnership,with Hallmark Insights to provide ... users of the ConXus health improvement platform. ... fulfillment services,for reward points earned by participants ...
Cached Medicine Technology:New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 2New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 3New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 4PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs 2
(Date:8/29/2014)... The Fresh Diet, America’s premier gourmet meal delivery ... meal plan. Originating from The Fresh Diet’s commitment to ... designed to satisfy customers seeking a convenient, worry-free option ... to the growing demand by customers for non-meat menu ... with 14% of Americans identifying vegetarian meals as ‘more ...
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 As ... Cooper City, Fla., understands that there’s a direct connection ... the knees, hips and back. "Since conventional shoe inserts ... design a solution of my own," he said. , ... Orthotic provides better support for the foot in order ...
(Date:8/29/2014)... 29, 2014 Williams Rejuva Center is ... their Latham aesthetic office. Dr. Edwin Williams, known ... the first surgeons in the area to employ the ... technique is faster and safer than similar products available ... a noninvasive procedure , designed to dramatically improve ...
(Date:8/29/2014)... Glendale Botox experts at Glenoaks Laser Center are ... of September. This special offer features 10 free units of ... can take advantage of this special offer to completely transform ... work with patients to determine if Botox or Juvederm is ... , Botox is a treatment made from the botulinum toxin. ...
(Date:8/29/2014)... Dennis Thompson HealthDay Reporter ... research performed during the early days of the Ebola outbreak ... the virus mutates and spreads. Researchers report in the ... have now determined the following: The Ebola strains ... dating back to the very first recorded outbreak of Ebola ...
Breaking Medicine News(10 mins):Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 2Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 3Health News:Williams Revjuva Center Brings Micro-Needling to Latham 2Health News:Glenoaks Laser Center is Now Offering a Special Promotion on Botox for the Month of September 2Health News:Gene Research Yields Insights Into Ebola Virus 2Health News:Gene Research Yields Insights Into Ebola Virus 3
... have observed a high resolution camera which detects tumours ... been comparing mammography with a technique called scintimammography, which ... is good at distinguishing between malignant and benign tumours, ... limitation of this kind of camera is that it ...
... to Japanese researchers, genetic abnormalities bound with marijuana-activated ... a lead researcher, of the Okayama University, observed ... use can result in schizophrenia or a considerablelly ... of the greatest mental health challenges in the ...
... looked at data for treatment of sub-arachnoid haemorrhage (SAH) in ... by bleeding into the brain do best in hospitals dealing ... within the blood supply surrounding the brain's exterior. It can ... nearly 10,000 patients admitted to 300 emergency departments was scanned, ...
... of antidepressant, called venlafaxine,assists patients with social anxiety disorder. ... and dread in relation to meeting and talking with ... situations a huge problem. Many of those with SAD ... condition can be hard to treat. ,Researchers ...
... ,According to a recent study, spending time in an Indian ... in a new study, India, looked at how traditional healing ... Muthuswamy in South India has long been a healing centre ... during a short period in 1000 were enrolled in the ...
... observed that, people suffering from heat diseases are better off ... for a few it might prove too much.People who are ... safe to enjoy a game of golf.// Researchers at the ... male golfers, aged between 50 and 75, half of whom ...
Cached Medicine News:Health News:Gene glitches connecting pot with Schizophrenia 2
4.625 inches, curved blade 4 mm....
Alvis foreign body spud 4 3/4 inches, oval curette 1 x 3 mm with fine point....
DIX foreign body spud 4 3/4 inches, 1.7 x 15 mm blade....
In reversible handle for removing foreign bodies....
Medicine Products: